Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7


Early Improvement in One Week Predicts the Treatment Response to Escitalopram in Patients with Social Anxiety Disorder: A Preliminary Study.

Oh KS, Shin E, Ha J, Shin D, Shin Y, Lim SW.

Clin Psychopharmacol Neurosci. 2016 May 31;14(2):161-7. doi: 10.9758/cpn.2016.14.2.161.


Episodic memories in anxiety disorders: clinical implications.

Zlomuzica A, Dere D, Machulska A, Adolph D, Dere E, Margraf J.

Front Behav Neurosci. 2014 Apr 24;8:131. doi: 10.3389/fnbeh.2014.00131. eCollection 2014. Review.


Strategy for treating selective serotonin reuptake inhibitor-resistant social anxiety disorder in the clinical setting: a randomised controlled trial protocol of cognitive behavioural therapy in combination with conventional treatment.

Yoshinaga N, Niitsu T, Hanaoka H, Sato Y, Ohshima F, Matsuki S, Kobori O, Nakazato M, Nakagawa A, Iyo M, Shimizu E.

BMJ Open. 2013 Feb 13;3(2). pii: e002242. doi: 10.1136/bmjopen-2012-002242. Print 2013.


Comparison of treatment adherence between selective serotonin reuptake inhibitors and moclobemide in patients with social anxiety disorder.

Lim SW, Kwon YS, Ha J, Yoon HG, Bae SM, Shin DW, Shin YC, Oh KS.

Psychiatry Investig. 2012 Mar;9(1):73-9. doi: 10.4306/pi.2012.9.1.73. Epub 2012 Jan 18.


Pharmacotherapy of anxiety disorders: a critical review.

Koen N, Stein DJ.

Dialogues Clin Neurosci. 2011;13(4):423-37. Review.


A placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder.

Blanco C, Heimberg RG, Schneier FR, Fresco DM, Chen H, Turk CL, Vermes D, Erwin BA, Schmidt AB, Juster HR, Campeas R, Liebowitz MR.

Arch Gen Psychiatry. 2010 Mar;67(3):286-95. doi: 10.1001/archgenpsychiatry.2010.11.


Resistant social anxiety disorder response to Escitalopram.

Pallanti S, Quercioli L.

Clin Pract Epidemiol Ment Health. 2006 Dec 13;2:35.

Supplemental Content

Support Center